![]() |
市場調查報告書
商品編碼
1896189
分子育種市場預測至2032年:按作物類型、技術、應用、最終用戶和地區分類的全球分析Molecular Breeding Market Forecasts to 2032 - Global Analysis By Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Forage & Fodder, and Other Crop Types), Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球分子育種市場規模預計在 2025 年達到 98.7 億美元,到 2032 年將達到 339.7 億美元,預測期內複合年成長率 (CAGR) 為 19.3%。分子育種是一種先進的動植物改良方法,它利用分子生物學工具更精確地辨識、選擇和組合理想的遺傳性狀。分子育種整合了標記輔助選擇、基因組選擇和 DNA 定序等技術,加速了傳統的育種過程。透過靶向與產量、品質、抗病性和抗逆性相關的特定基因,分子育種縮短了育種時間,提高了效率,並有助於培育適應不同環境和農業條件的優良品種。
對能夠抵禦氣候變遷的永續農業的需求
農民和政府正將永續農業系統列為優先事項,以確保長期糧食安全。分子育種技術能夠精準辨識並選擇所需性狀,從而快速培育出氣候適應型作物。人們對資源高效型農業的日益關注,推動了先進育種技術的應用。公共和私人對永續農業研發的投資,進一步增強了市場動力。減少化學投入的需求,也促使人們關注具有遺傳耐受性的品種。這些因素共同作用,顯著擴大了全球分子育種市場在不同農業氣候區域的規模。
高昂的初始成本和基礎建設需求
對基因分型平台和數據分析工具等先進基礎設施的需求增加了營運成本。由於資金有限,中小規模的育種計畫往往難以採用這些技術。在發展中地區,研究設施的匱乏進一步阻礙了技術的大規模應用。高昂的技術授權和智慧財產權費用也加重了經濟負擔。漫長的研發週期會延遲市場參與企業的投資報酬率。這些成本相關的挑戰仍然是技術更廣泛應用的障礙,尤其是在資源匱乏的機構中。
生物強化和營養增強作物
分子育種技術描述了提高主糧作物中鐵、鋅、維生素和其他營養素等微量元素含量的精確方法。營養強化品種可以在不改變傳統飲食習慣的情況下解決隱性飢餓(營養不良)問題。各國政府和國際組織正在支持以改善公眾健康為目標的營養育種舉措。基因組學的進步使得快速識別與營養性狀相關的基因成為可能。研究機構和種子企業之間的合作正在加速改良作物的商業化。人們對營養日益成長的關注為分子育種市場創造了巨大的成長機會。
來自其他育種技術的競爭
CRISPR等技術能夠更快、更精準地開發特定應用所需的性狀。一些育種者正將投資轉向下一代工具,以縮短產品開發週期。每項技術的監管不確定性可能會影響其區域應用模式。技術創新的快速發展給分子育種服務提供者帶來了持續提升自身能力的壓力。育種平台之間差異化程度有限,可能導致競爭對手之間相互競爭。替代技術的湧現也可能對分子育種解決方案的長期優勢構成挑戰。
新冠疫情擾亂了農業研究活動,由於田間試驗受限,育種測試也因此延誤。供應鏈中斷影響了實驗室試劑和育種材料的供應。然而,這場危機凸顯了建構韌性糧食系統的重要性,並加速了人們對先進育種技術的興趣。研究機構加快了數據分析和遠端協作數位化工具的應用。資金優先事項也進行了重新調整,以確保在不確定時期作物產量和糧食安全。種子企業專注於快速開發抗逆性強、產量高的品種。在後疫情時代,分子育種作為增強農業韌性的策略工具,再次受到關注。
預計在預測期內,提高產量細分市場將佔據最大的市場佔有率。
預計在預測期內,產量改良領域將佔據最大的市場佔有率,因為提高作物產量仍然是面臨土地資源限制和糧食需求不斷成長的農民的首要目標。分子標記使育種者能夠更準確、更有效率地選擇高產性狀。與傳統方法相比,這些技術縮短了培育優良品種所需的時間。世界各國政府都在大力支持以產量為導向的育種,以提高糧食自給率。高產品種還能提高農場的盈利,進而促進其廣泛應用。
預計在預測期內,生技公司板塊的複合年成長率將最高。
由於生物技術公司對農業生產和經濟收入的直接影響,預計在預測期內將實現最高成長率。人口成長給全球作物生產系統帶來持續壓力。分子育種有助於釋放遺傳潛力,從而在各種條件下提高產量。農民更傾向於選擇產量高且跨季節表現穩定的品種。種子企業正優先發展這一領域,因為其市場接受度高且易於規模化。公共育種計畫也致力於提高作物在逆境環境下的產量穩定性。
預計北美地區將在預測期內佔據最大的市場佔有率,因為該地區的公司在基因組學、生物資訊學和分子工具的整合方面處於領先地位。強大的研發能力推動了新型育種解決方案的快速創新和商業化。與農業機構的策略合作正在擴大技術的覆蓋範圍。不斷成長的創業投資投資支持著生物技術主導育種平台的規模化發展。提供客製化性狀解決方案的能力正在增強競爭優勢。
由於亞太地區高度重視創新和技術應用,預計該地區在預測期內將實現最高的複合年成長率。這些參與企業正利用先進的分子技術來縮短育種週期並提高精準度。對特種和高性能作物日益成長的需求正在推動生物技術主導解決方案的發展。完善的智慧財產權架構鼓勵私部門參與。與種子企業的合作正在加速市場滲透。向新興經濟體的擴張正在創造新的收入來源。
According to Stratistics MRC, the Global Molecular Breeding Market is accounted for $9.87 billion in 2025 and is expected to reach $33.97 billion by 2032 growing at a CAGR of 19.3% during the forecast period. Molecular breeding is an advanced plant and animal improvement approach that uses molecular biology tools to identify, select, and combine desirable genetic traits with greater precision. It integrates techniques such as marker-assisted selection, genomic selection, and DNA sequencing to accelerate traditional breeding processes. By targeting specific genes linked to yield, quality, disease resistance, and stress tolerance, molecular breeding reduces breeding time, improves efficiency, and enhances the development of superior varieties suited to diverse environmental and agricultural conditions.
Demand for climate-resilient & sustainable agriculture
Farmers and governments are increasingly prioritizing sustainable agricultural systems to ensure long-term food security. Molecular breeding enables the rapid development of climate-resilient crops by precisely identifying and selecting desirable traits. Rising awareness about resource-efficient farming is encouraging adoption of advanced breeding approaches. Public and private investments in sustainable agriculture research are further strengthening market momentum. The push to reduce chemical inputs is also driving interest in genetically resilient cultivars. Together, these factors are significantly expanding the global molecular breeding market across diverse agro-climatic regions.
High initial costs & infrastructure needs
The need for sophisticated infrastructure such as genotyping platforms and data analytics tools raises operational costs. Small and medium-sized breeding programs often face difficulties in adopting these technologies due to limited financial resources. In developing regions, inadequate research facilities further constrain large-scale implementation. The high cost of technology licensing and intellectual property adds to the financial burden. Long development timelines can delay returns on investment for market players. These cost-related challenges continue to limit broader adoption, particularly among resource-constrained institutions.
Biofortified & nutritionally enhanced crops
Molecular breeding offers precise tools to improve micronutrient content such as iron, zinc, and vitamins in staple crops. Biofortified varieties can address hidden hunger without altering traditional dietary habits. Governments and international organizations are supporting nutrition-focused breeding initiatives to improve public health outcomes. Advances in genomics are enabling faster identification of genes linked to nutritional traits. Collaboration between research institutes and seed companies is accelerating commercialization of enhanced crops. This growing focus on nutrition presents significant growth opportunities for the molecular breeding market.
Competition from alternative breeding tech
Techniques like CRISPR offer faster trait development with greater precision in certain applications. Some breeders are shifting investments toward these next-generation tools to shorten product development cycles. Regulatory uncertainty around different technologies can influence adoption patterns across regions. The rapid pace of innovation increases pressure on molecular breeding providers to continuously upgrade capabilities. Limited differentiation between breeding platforms may intensify competitive rivalry. As alternative technologies gain traction, they could challenge the long-term dominance of molecular breeding solutions.
The COVID-19 pandemic disrupted agricultural research activities and delayed breeding trials due to restricted field access. Supply chain interruptions affected the availability of laboratory reagents and breeding materials. However, the crisis underscored the importance of resilient food systems and accelerated interest in advanced breeding technologies. Research organizations increasingly adopted digital tools for data analysis and remote collaboration. Funding priorities shifted toward ensuring crop productivity and food security during uncertain times. Seed companies focused on fast-tracking resilient and high-yield varieties. In the post-pandemic period, molecular breeding is gaining renewed attention as a strategic tool for agricultural resilience.
The yield improvement segment is expected to be the largest during the forecast period
The yield improvement segment is expected to account for the largest market share during the forecast period, due to enhancing crop productivity remains a primary objective for farmers facing land constraints and growing food demand. Molecular markers enable breeders to efficiently select high-yield traits with greater accuracy. These techniques reduce the time required to develop superior varieties compared to conventional methods. Governments are strongly supporting yield-focused breeding to strengthen food self-sufficiency. High-yield varieties also improve farm profitability, encouraging widespread adoption.
The biotechnology firms segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the biotechnology firms segment is predicted to witness the highest growth rate, driven by its direct impact on agricultural output and economic returns. Increasing population levels are placing constant pressure on global crop production systems. Molecular breeding helps unlock genetic potential that enhances productivity under varying conditions. Farmers prefer yield-enhancing varieties that offer consistent performance across seasons. Seed companies prioritize this segment due to faster market acceptance and scalability. Public breeding programs are also focusing on yield stability in stress-prone environments.
During the forecast period, the North America region is expected to hold the largest market share, due to these companies are at the forefront of integrating genomics, bioinformatics, and molecular tools. Strong R&D capabilities enable them to rapidly innovate and commercialize new breeding solutions. Strategic partnerships with agricultural institutes are expanding their technology reach. Increased venture capital funding is supporting the scale-up of biotech-driven breeding platforms. Their ability to offer customized trait solutions enhances competitive advantage.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to their strong focus on innovation and technology adoption. These players leverage advanced molecular techniques to reduce breeding cycles and improve accuracy. Growing demand for trait-specific and high-performance crops favors biotech-led solutions. Supportive intellectual property frameworks are encouraging private sector participation. Collaborations with seed companies are accelerating market penetration. Expansion into emerging economies is opening new revenue streams.
Key players in the market
Some of the key players in Molecular Breeding Market include Bayer AG, KeyGene, Corteva Ag, DanBred, Syngenta, Intertek, KWS SAAT, LemnaTec, Limagrain, SGS SA, Eurofins, LGC Limited, Illumina, Inc., Charles Ri, and Thermo Fi.
In October 2025, SALIC and Syngenta Signed Agreement to Explore Joint Agriculture Projects that Enhance Food Security in Saudi Arabia and Around the World. This collaboration with Syngenta reflects SALIC's commitment to innovation, sustainability, and global partnerships. Together, we aim to help transform agriculture by integrating technology, knowledge, and responsible practices empowering farmers, conserving resources, and building resilient food systems that strengthen Saudi Arabia's food security and support future generations worldwide.
In August 2025, DuPont de Nemours, Inc., and Corteva, Inc. announced a settlement to comprehensively resolve all pending environmental and other claims by the State of New Jersey against the Companies in various litigation matters and other state directives. The Settlement will resolve all legacy contamination claims related to the companies' current and former operating sites (Chambers Works, Parlin, Pompton Lakes and Repauno) and claims of statewide PFAS contamination unrelated to those sites, including from the use of aqueous film forming foam.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.